PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Product: Insulin soluble
Presentation Product Chemical substance Chapter Items dispensed
Insulin soluble human 100units/ml inj 10ml vials
0601011N0AAALAL
Insulin soluble Soluble insulin (Neutral insulin) Endocrine System 6
Insulin soluble porcine 100units/ml inj 10ml vials
0601011N0AAACAC
Insulin soluble Soluble insulin (Neutral insulin) Endocrine System 6
Insulin soluble human 100units/ml inj 3ml cartridges
0601011N0AAAPAP
Insulin soluble Soluble insulin (Neutral insulin) Endocrine System 1
Insulin soluble bovine 100units/ml inj 1.5ml cartridges
0601011N0AAATAT
Insulin soluble Soluble insulin (Neutral insulin) Endocrine System No data available
Insulin soluble bovine 100units/ml inj 10ml vials
0601011N0AAAAAA
Insulin soluble Soluble insulin (Neutral insulin) Endocrine System No data available
Insulin soluble bovine 100units/ml inj 3ml cartridges
0601011N0AAAYAY
Insulin soluble Soluble insulin (Neutral insulin) Endocrine System No data available
Insulin soluble human 100units/ml inj 1.5ml cartridges
0601011N0AAADAD
Insulin soluble Soluble insulin (Neutral insulin) Endocrine System No data available
Insulin soluble human 100units/ml inj 3ml pf dispos dev
0601011N0AAAMAM
Insulin soluble Soluble insulin (Neutral insulin) Endocrine System No data available
Insulin soluble human 100units/ml inj 5ml vials
0601011N0AAAWAW
Insulin soluble Soluble insulin (Neutral insulin) Endocrine System No data available
Insulin soluble porcine 100units/ml inj 1.5ml cartridges
0601011N0AAAUAU
Insulin soluble Soluble insulin (Neutral insulin) Endocrine System No data available
Insulin soluble porcine 100units/ml inj 3ml cartridges
0601011N0AAAZAZ
Insulin soluble Soluble insulin (Neutral insulin) Endocrine System No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.